Answers are grounded in this paper and cite their sources.
Background: The measurement of meropenem plasma concentrations is employed for dosing regimen individualization. The aim of this study was to develop and validate a LC–MS/MS assay for quantification of meropenem in capillary plasma microsamples. Methods: Samples were prepared by protein precipitation with acetonitrile, followed by clean-up with dichloromethane. The method was validated and applied to 12 paired samples of venous and capillary plasma. Results: The method was linear in the range of 0.5–50 μg/ml. Matrix effects were minimal. Inter- and intra-assay were 3.8–7.9% and 2.7–5.5%, respectively, while accuracy was 91.7–100.6%. Concentrations in capillary and venous plasma were highly correlated. Conclusion: An assay for the quantification of meropenem in capillary plasma microsamples was fully validated, showing potential for clinical application.
No takes yet. Share an insight, caveat, or question.
Busato et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: